Intravenous Albumin for the Prevention of Hemodynamic Instability During Sustained Low-Efficiency Dialysis. A Randomized Controlled Feasibility Trial. (The SAFER-SLED Study)
Edward G. Clark(University of Ottawa), Swapnil Hiremath(Apple (Israel)), Elham Sabri(Ottawa Hospital), Mark Canney(University of Ottawa), Jennifer Kong(Ottawa Hospital), Pierre-Antoine Brown(University of Ottawa), Gregory L. Hundemer(University of Ottawa), Irene Watpool(Ottawa Hospital), Tim Ramsay(University of Ottawa), Lauralyn McIntyre(Ottawa Hospital Research Institute), Manish M. Sood(Ottawa Hospital)
Cited by 1
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
Age of Transfused Blood in Critically Ill Adults
|New England Journal of Medicine|2015|559